145 results on '"Juanpere, Nuria"'
Search Results
2. Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study
3. A Multicentre Clinical Trial Evaluating a Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer
4. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
5. Dual mTOR1/2 inhibitor sapanisertib (TAK-228) in combination with weekly paclitaxel in patients with previously treated metastatic urothelial carcinoma: a phase II open-label study.
6. Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis
7. A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer: Preclinical Evaluation and Interim Results From a Multicenter Clinical Trial
8. Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer
9. Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome
10. Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status
11. Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
12. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
13. Supplementary Data from Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer
14. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
15. Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland
16. MP06-02 NON-MUSCLE-INVASIVE MICROPAPILLARY BLADDER CANCER HAS A DISTINCT LNCRNA PROFILE ASSOCIATED WITH UNFAVORABLE PROGNOSIS
17. PD37-11 INTERIM RESULTS FROM A MULTICENTER CLINICAL TRIAL EVALUATING A DROP-IN GAMMA PROBE FOR SENTINEL LYMPH NODE DISSECTION IN PROSTATE CANCER
18. A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer: SEC14L1 and TCEB1 Genes Are Potential Markers of Progression
19. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer
20. PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
21. PROGNOSTIC VALUE OF DNA DAMAGE RESPONSE RELATED PROTEINS IN NON-MUSCLE INVASIVE BLADDER CANCER: MP45-12
22. Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas
23. Granulomatosis linfomatoide con presentación neurológica. A propósito de un caso y revisión de la literatura
24. SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence
25. FGFR3 mutations in prostate cancer: association with low-grade tumors
26. KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations
27. Quality of life in patients with non–muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study
28. Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases
29. Paragastric paraganglioma: A case report with unusual alveolar pattern and myxoid component
30. Value of p16INK4a in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology
31. Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer
32. Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy
33. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG ‐rearranged prostate cancer
34. MP09-18 MODIFIED INJECTION TECHNIQUE IN SENTINEL LYMPH NODE DETECTION IN PROSTATE CANCER: TARGETING THE INDEX LESION
35. Differential expression of SRSF2 contribute to the splicing changes related to micropapillary variant histology in nonmuscle-invasive bladder cancer (NMIBC).
36. B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen
37. Combined alteration of ERG, prostein and PTEN identifies a subset of high grade, high stage prostate cancers with heterogeneous gleason score in needle biopsy cores
38. Phosphodiesterase 4b expression in a canine experimental model of prostatic hyperplasia
39. ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
40. Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse (PLoS ONE (2014))
41. MP45-12 PROGNOSTIC VALUE OF DNA DAMAGE RESPONSE RELATED PROTEINS IN NON-MUSCLE INVASIVE BLADDER CANCER
42. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
43. Twelve Core Template Prostate Biopsy is an Unreliable Tool to Select Patients Eligible for Focal Therapy
44. Correction: Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse
45. Erratum: Corrigendum: B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
46. Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse
47. B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
48. Paper # 232: Polyethylene Particles in Synovial Fluid in Revision Surgery of Failed Total Knee Prosthesis
49. Paragastric paraganglioma: A case report with unusual alveolar pattern and myxoid component
50. Abstract 1168: Urothelial cell carcinomas harbor very frequent mutations in FGFR3-PI3K-AKT pathway and highest prevalence of mutations is related to low-grade tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.